Navigation Links
ERT to Present at the UBS 20th Annual Global Healthcare Services Conference on February 8, 2010
Date:2/1/2010

PHILADELPHIA, Feb. 1 /PRNewswire-FirstCall/ -- ERT (Nasdaq: ERES), announced today that Dr. Michael J. McKelvey, the Company's President and CEO, and Keith Schneck, the Company's Executive Vice President and CFO, are scheduled to present at the UBS 20th Annual Global Healthcare Services Conference at 3:30 PM EST on February 8, 2010 in New York City.

Interested parties may access the presentation by visiting the Company's corporate website at http://www.ert.com.  The webcast may also be accessed at http://cc.talkpoint.com/ubsx001/020810a_ke/?entity=33_YR2H1UU.  The webcast will be available via replay for 90 days.

About ERT

Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.ert.com) is a global provider of technology and services to the biopharmaceutical, medical device, and related industries. The Company is the market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The Company also provides technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties, which could cause actual results to differ materially from those expressed or implied from such statements.  These risks and uncertainties include, without limitation, the Company's ability to obtain new contracts, variability in size, scope and duration of projects, integration of acquisitions, competitive factors, technological development, market demand, and other factors described in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

SOURCE ERT

RELATED LINKS
http://www.ert.com

'/>"/>

SOURCE ERT
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sangamo BioSciences Announces Presentation at BIO CEO & Investor Conference
2. Telik Announces Presentation and Webcast at 12th Annual BIO CEO & Investor Conference
3. NOVAVAX to Present at Phacilitate Vaccine Forum Washington 2010
4. NeurogesX to Present at J.P. Morgan Health Care Conference
5. Poniard Pharmaceuticals, Inc. to Present Additional Cancer Treatment Data Found Significant by TapeBeat.Com Investors
6. Oxygen Biotherapeutics, Inc. Outlines Plans for New Products During Investor Conference Presentation
7. Resverlogix Presenting at Biotech Showcase
8. Amira Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
9. Profectus Biosciences to Present at Key Investor Conference in January 2010
10. Sinovacs CEO Weidong Yin Presented with Annual Innovation Award by China Central Television
11. Institut Paoli Calmettes and Ipsogen Presented a New Study Supporting the Pivotal Role of Tumor Grade in Chemotherapy Prescription at the 32nd Annual San Antonio Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... Executive search firm, Slone Partners, announces the placement of ... distinguished life sciences expert with a proven track record in strategic global business ... of services related to laboratory testing and analysis for the pharmaceutical, medical device, ...
(Date:3/27/2017)... Ltd., a Russian portfolio company of Maxwell Biotech Venture Fund (MBVF), today announced positive ... therapy regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 is a new small ... the US National Institutes of Health. Continue Reading ... ... ...
(Date:3/27/2017)... ... 2017 , ... A research team led by Mai Lam, ... Video Journal, the world’s first peer-reviewed scientific video journal. The article demonstrates a ... disease (CAD). Lam is an assistant professor at the Department of Biomedical Engineering ...
(Date:3/24/2017)... , March 24, 2017  Infectex Ltd., a ... today announced positive results of a Phase 2b-3 clinical ... regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 ... at Sequella, Inc. ( USA ) and ... A total of 140 patients were enrolled in a ...
Breaking Biology Technology:
(Date:3/20/2017)... 2017 PMD Healthcare announces the release of ... Management System (WMS), a remote, real-time lung health monitoring ... Healthcare is a Medical Device, Digital Health, and Chronic ... creating innovative solutions that empower people to improve their ... PMD developed the first ever personal spirometer, Spiro PD, ...
(Date:3/9/2017)... , Australia , March 9, 2017 ... data at the prestigious World Lung Imaging Workshop at ... Andreas Fouras , was invited to deliver the latest ... medicine. This globally recognised event brings together leaders at ... the latest developments in lung imaging. ...
(Date:3/7/2017)... LAKE CITY , March 7, 2017   ... that help top global companies identify the best talent, ... as Chief Sales Officer (CSO) and Diana ... Kucer,s appointments round out a seasoned executive team poised to ... and beyond, building on a year of record bookings ...
Breaking Biology News(10 mins):